Showing results (91-100 of 777) with videos related to

Sort By:
Pageof 78
Expert Opinion on Drug Metabolism & Toxicology|April 20, 2012
Perifosine , an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activityPaul G Richardson, Cathy Eng, Jill Kolesar, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 16, 2005
Perspectives for combination therapy to overcome drug-resistant multiple myelomaLaurence Catley, Yu-Tzu Tai, Dharminder Chauhan, et al.
Expert Opinion on Investigational Drugs|October 10, 2007
The therapeutic role of targeting protein kinase C in solid and hematologic malignanciesKlaus Podar, Marc S Raab, Dharminder Chauhan, et al.
Blood|August 30, 2002
2-Methoxyestradiol overcomes drug resistance in multiple myeloma cellsDharminder Chauhan, Laurence Catley, Teru Hideshima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivoTeru Hideshima, Paola Neri, Pierfranchesco Tassone, et al.
Experimental Hematology|July 24, 2002
beta-lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cellsDeepak Gupta, Klaus Podar, Yu Tzu Tai, et al.
Cancer Research|October 30, 2003
Fluorescence imaging of multiple myeloma cells in a clinically relevant SCID/NOD in vivo model: biologic and clinical implicationsConstantine S Mitsiades, Nicholas S Mitsiades, Ron T Bronson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2006
The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myelomaKlaus Podar, Giovanni Tonon, Martin Sattler, et al.
Leukemia|May 20, 2020
Proteomic analysis identifies mechanism(s) of overcoming bortezomib resistance via targeting ubiquitin receptor Rpn13Ting Du, Yan Song, Arghya Ray, et al.
Expert Review of Anticancer Therapy|July 9, 2005
Proteasome inhibition as a therapeutic strategy for hematologic malignanciesConstantine S Mitsiades, Nicholas Mitsiades, Teru Hideshima, et al.
Pageof 78